GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Asset Turnover

Halberd (Halberd) Asset Turnover : 0.21 (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Halberd's Revenue for the six months ended in Jul. 2023 was $0.00 Mil. Halberd's Total Assets for the quarter that ended in Jul. 2023 was $0.01 Mil. Therefore, Halberd's Asset Turnover for the quarter that ended in Jul. 2023 was 0.21.

Asset Turnover is linked to ROE % through Du Pont Formula. Halberd's annualized ROE % for the quarter that ended in Jul. 2023 was 109.79%. It is also linked to ROA % through Du Pont Formula. Halberd's annualized ROA % for the quarter that ended in Jul. 2023 was -6,262.07%.


Halberd Asset Turnover Historical Data

The historical data trend for Halberd's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Asset Turnover Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Asset Turnover
0.02 0.05 0.21

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Asset Turnover 0.02 0.05 0.21

Competitive Comparison of Halberd's Asset Turnover

For the Biotechnology subindustry, Halberd's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Halberd's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Halberd's Asset Turnover falls into.



Halberd Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Halberd's Asset Turnover for the fiscal year that ended in Jul. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jul. 2023 )/( (Total Assets (A: Jul. 2022 )+Total Assets (A: Jul. 2023 ))/ count )
=0.003/( (0.017+0.012)/ 2 )
=0.003/0.0145
=0.21

Halberd's Asset Turnover for the quarter that ended in Jul. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jul. 2023 )/( (Total Assets (Q: Jul. 2022 )+Total Assets (Q: Jul. 2023 ))/ count )
=0.003/( (0.017+0.012)/ 2 )
=0.003/0.0145
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Halberd  (OTCPK:HALB) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Halberd's annulized ROE % for the quarter that ended in Jul. 2023 is

ROE %**(Q: Jul. 2023 )
=Net Income/Total Stockholders Equity
=-0.908/-0.827
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.908 / 0.006)*(0.006 / 0.0145)*(0.0145/ -0.827)
=Net Margin %*Asset Turnover*Equity Multiplier
=-15133.33 %*0.4138*-0.0175
=ROA %*Equity Multiplier
=-6,262.07 %*-0.0175
=109.79 %

Note: The Net Income data used here is two times the semi-annual (Jul. 2023) net income data. The Revenue data used here is two times the semi-annual (Jul. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Halberd's annulized ROA % for the quarter that ended in Jul. 2023 is

ROA %(Q: Jul. 2023 )
=Net Income/Total Assets
=-0.908/0.0145
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.908 / 0.006)*(0.006 / 0.0145)
=Net Margin %*Asset Turnover
=-15133.33 %*0.4138
=-6,262.07 %

Note: The Net Income data used here is two times the semi-annual (Jul. 2023) net income data. The Revenue data used here is two times the semi-annual (Jul. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Halberd Asset Turnover Related Terms

Thank you for viewing the detailed overview of Halberd's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236